Clinical trial
Comparison of Insulin Glargine Versus Biphasic Insulin Aspart 30/70 or Biphasic…
NCT00184626 · Novo Nordisk A/S, Industry · Completed
Key facts
| NCT number | NCT00184626 |
|---|---|
| Title | Comparison of Insulin Glargine Versus Biphasic Insulin Aspart 30/70 or Biphasic Insulin Aspart 30/70 in Combination With Metformin in Subjects With Type 2 Diabetes. |
| Official title | Safety and Efficacy of Insulin Glargine Versus Biphasic Insulin Aspart 30/70 or Biphasic Insulin Aspart 30/70 in Combination With Metformin in Subjects With Type 2 Diabetes. |
| Lead sponsor | Novo Nordisk A/S, Industry |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Diabetes, Diabetes Mellitus, Type 2 |
| Intervention type | Drug |
| Interventions | biphasic insulin aspart, insulin glargine, metformin |
| Enrollment | 97 |
| Start date | Sep 10, 2004 |
| Primary completion | Oct 24, 2005 |
| Completion | Oct 24, 2005 |
| First posted | Sep 16, 2005 |
| Last update posted | Feb 24, 2017 |
| Countries | Turkey (Türkiye) |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: